Gold prices remain near yearly lows as BMO Capital Markets cuts its year-end forecast to $4,625 an ounce, citing the Federal Reserve's hawkish stance and rising geopolitical tensions, especially in the Middle East. Despite short-term struggles, BMO expects gold to rebound above $5,000 by early 2027, driven by de-dollarization trends and emerging market demand. Silver prices are also downgraded for the near term but expected to recover by early 2027 due to industrial demand and infrastructure investments. The main risk to metals remains aggressive U.S. monetary policy, with rate hikes likely before year-end, dampening metal prices in the short run.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
